Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Porter

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Blood|February 9, 2000
Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemiaB A Davis, J B Porter
Biochemical Society Transactions|February 1, 1997
Ribonucleotide reductase, lipoxygenase and the intracellular low-molecular-weight iron poolC E Cooper, J B Porter
Analytical Biochemistry|June 1, 1990
Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluidsS Singh, R C Hider, J B Porter
The New England Journal of Medicine|April 16, 1981
Acute cholecystitis and thiazidesJ B Porter, H Jick, B J Dinan
Analytical Biochemistry|May 1, 1990
A direct method for quantification of non-transferrin-bound ironS Singh, R C Hider, J B Porter
Anaesthesia|July 5, 2001
Coronary artery bypass graft surgery in a patient with haemoglobin SC diseaseW A Marchant, S Wright, J B Porter
American Journal of Public Health|June 1, 1984
Cancer of the breast, colon, ovary, and testis in the United States: rates 1970-78 from a hospital reporting systemJ B Porter, A M Walker, H Jick
Pharmacotherapy|September 1, 1981
Malignant liver tumor associated with oral contraceptive useJ B Porter, H Jick, J T Ylvisaker
Obstetrics and Gynecology|July 1, 1987
Mortality among oral contraceptive usersJ B Porter, H Jick, A M Walker
Seminars in Hematology|April 1, 1990
Update on the hydroxypyridinone oral iron-chelating agentsJ B Porter, R C Hider, E R Huehns
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Blood|February 9, 2000
Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemiaB A Davis, J B Porter
Biochemical Society Transactions|February 1, 1997
Ribonucleotide reductase, lipoxygenase and the intracellular low-molecular-weight iron poolC E Cooper, J B Porter
Analytical Biochemistry|June 1, 1990
Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluidsS Singh, R C Hider, J B Porter
The New England Journal of Medicine|April 16, 1981
Acute cholecystitis and thiazidesJ B Porter, H Jick, B J Dinan
Analytical Biochemistry|May 1, 1990
A direct method for quantification of non-transferrin-bound ironS Singh, R C Hider, J B Porter
Anaesthesia|July 5, 2001
Coronary artery bypass graft surgery in a patient with haemoglobin SC diseaseW A Marchant, S Wright, J B Porter
American Journal of Public Health|June 1, 1984
Cancer of the breast, colon, ovary, and testis in the United States: rates 1970-78 from a hospital reporting systemJ B Porter, A M Walker, H Jick
Pharmacotherapy|September 1, 1981
Malignant liver tumor associated with oral contraceptive useJ B Porter, H Jick, J T Ylvisaker
Obstetrics and Gynecology|July 1, 1987
Mortality among oral contraceptive usersJ B Porter, H Jick, A M Walker
Seminars in Hematology|April 1, 1990
Update on the hydroxypyridinone oral iron-chelating agentsJ B Porter, R C Hider, E R Huehns
Pageof 10